This topic was reviewed by the California Technology Assessment Forum on October 18, 2006. It was recommended that the use of Microvolt T-Wave Alternans testing to risk stratify patients for implantable cardioverter-defibrillator placement for prevention of sudden cardiac death does not meet CTAF Criteria because it is unclear as of yet how to use this test to improve medical management in a way that will benefit the patient.

Full Assessment:

Download (PDF, 210 KB)